BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pozo L, Bello F, Suarez A, Ochoa-Martinez FE, Mendez Y, Chang CH, Surani S. Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence. World J Diabetes 2019; 10(5): 291-303 [PMID: 31139316 DOI: 10.4239/wjd.v10.i5.291]
URL: https://www.wjgnet.com/1948-9358/full/v10/i5/291.htm
Number Citing Articles
1
Claudiu Morgovan, Smaranda Adina Cosma, Madalina Valeanu, Anca Maria Juncan, Luca Liviu Rus, Felicia Gabriela Gligor, Anca Butuca, Delia Mirela Tit, Simona Bungau, Steliana Ghibu. An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance SystemInternational Journal of Environmental Research and Public Health 2020; 17(12): 4456 doi: 10.3390/ijerph17124456
2
Kunika Saini, Smriti Sharma, Yousuf Khan. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literatureFrontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1130625
3
Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee. Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation and Migration in Vascular Smooth Muscle Cells and Ameliorates Phosphate-Induced Vascular Smooth Muscle Cells CalcificationDiabetes & Metabolism Journal 2024; 48(1): 83 doi: 10.4093/dmj.2022.0363
4
Yuka Ikeda, Nozomi Nagase, Ai Tsuji, Yasuko Kitagishi, Satoru Matsuda. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs <i>via</i> the modulation of AKT-signaling pathway in Alzheimer’s diseaseWorld Journal of Biological Chemistry 2021; 12(6): 104-113 doi: 10.4331/wjbc.v12.i6.104
5
Jean Claude Mbanya, Pablo Aschner, Juan J. Gagliardino, Hasan İlkova, Fernando Lavalle, Ambady Ramachandran, Jean-Marc Chantelot, Juliana C. N. Chan. Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS)Diabetologia 2021; 64(6): 1246 doi: 10.1007/s00125-021-05406-6
6
Manik Chhabra, Kota Vidyasagar, Sai Krishna Gudi, Jatin Sharma, Rishabh Sharma, Muhammed Rashid, Jie V. Zhao. Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studiesPLOS ONE 2022; 17(7): e0269531 doi: 10.1371/journal.pone.0269531
7
Hossein Babatabar Darzi, Amir Vahedian‐Azimi, Saeed Ghasemi, Abbas Ebadi, Thozhukat Sathyapalan, Amirhossein Sahebkar. The effect of aromatherapy with rose and lavender on anxiety, surgical site pain, and extubation time after open‐heart surgery: A double‐center randomized controlled trialPhytotherapy Research 2020; 34(10): 2675 doi: 10.1002/ptr.6698
8
Glucagon-like Peptide 1, Brain, Neurodegenerative Diseases: A Modern ViewBulletin of Science and Practice 2020; 6(4): 153 doi: 10.33619/2414-2948/53/19
9
Maddalena Grieco, Alessandra Giorgi, Maria Cristina Gentile, Maria d’Erme, Susanna Morano, Bruno Maras, Tiziana Filardi. Glucagon-Like Peptide-1: A Focus on Neurodegenerative DiseasesFrontiers in Neuroscience 2019; 13 doi: 10.3389/fnins.2019.01112
10
Ping Yang, Jian Feng, Qing Peng, Xing Liu, Zhongcai Fan. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under DiabetesOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/9570616
11
Silvia Costantini, Caterina Conte. Bone health in diabetes and prediabetesWorld Journal of Diabetes 2019; 10(8): 421-445 doi: 10.4239/wjd.v10.i8.421
12
Mabel Yau, Cemre Robinson, Mark A. Sperling. Encyclopedia of Bone Biology2020; : 10 doi: 10.1016/B978-0-12-801238-3.11556-9
13
Hakan Doğruel, Hatice Tülüce Atlım, Mustafa Aydemir, Nusret Yılmaz, Ramazan Sarı. Comparative evaluation of clinical outcomes of dapagliflozin and empagliflozin in type-2 diabetes mellitusIrish Journal of Medical Science (1971 -) 2023; 192(5): 2189 doi: 10.1007/s11845-022-03262-w
14
María Esther Rubio-Ruíz, Juan Carlos Plata-Corona, Elizabeth Soria-Castro, Julieta Anabell Díaz-Juárez, María Sánchez-Aguilar. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative ReviewCells 2024; 13(17): 1488 doi: 10.3390/cells13171488